PYRROLIDINE DERIVATIVE OR SALT THEREOF

[Problem] To provide a compound which may be used in treating diseases in which a calcium sensing receptor (CaSR) is concerned, particularly hyperparathyroidism. [Means for Resolution] It was found that novel pyrrolidine derivatives which are characterized by the possession of aminomethyl group subs...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TERADA, YOH, KAMIKUBO, TAKASHI, SANAGI, MASANAO, TAKAHASHI, TAISUKE, HACHIYA, SHUNICHIRO, SEO, RYUSHI, MUKAI, HANA, MATSUURA, KEISUKE, YOSHIHARA, KOUSEI, OKU, MAKOTO, SHIN, TAKASHI
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TERADA, YOH
KAMIKUBO, TAKASHI
SANAGI, MASANAO
TAKAHASHI, TAISUKE
HACHIYA, SHUNICHIRO
SEO, RYUSHI
MUKAI, HANA
MATSUURA, KEISUKE
YOSHIHARA, KOUSEI
OKU, MAKOTO
SHIN, TAKASHI
description [Problem] To provide a compound which may be used in treating diseases in which a calcium sensing receptor (CaSR) is concerned, particularly hyperparathyroidism. [Means for Resolution] It was found that novel pyrrolidine derivatives which are characterized by the possession of aminomethyl group substituted with arylalkyl group or the like, or salts thereof, have excellent CaSR agonistic regulatory activity and also have excellent selectivity with CYP2D6 inhibitory activity having a possibility of causing drug interaction. Based on the above, these novel pyrrolidine derivatives are useful as therapeutic agents for treating diseases in which CaSR is concerned (hyperparathyroidism, renal osteodystrophy, hypercalcemia and the like).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CA2608957A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CA2608957A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CA2608957A13</originalsourceid><addsrcrecordid>eNrjZFALiAwK8vfxdPH0c1VwcQ3yDHMM8QxzVfAPUgh29AlRCPFwDXL1d-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjkZmBhaWpuaOhsZEKAEAkkAjQw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRROLIDINE DERIVATIVE OR SALT THEREOF</title><source>esp@cenet</source><creator>TERADA, YOH ; KAMIKUBO, TAKASHI ; SANAGI, MASANAO ; TAKAHASHI, TAISUKE ; HACHIYA, SHUNICHIRO ; SEO, RYUSHI ; MUKAI, HANA ; MATSUURA, KEISUKE ; YOSHIHARA, KOUSEI ; OKU, MAKOTO ; SHIN, TAKASHI</creator><creatorcontrib>TERADA, YOH ; KAMIKUBO, TAKASHI ; SANAGI, MASANAO ; TAKAHASHI, TAISUKE ; HACHIYA, SHUNICHIRO ; SEO, RYUSHI ; MUKAI, HANA ; MATSUURA, KEISUKE ; YOSHIHARA, KOUSEI ; OKU, MAKOTO ; SHIN, TAKASHI</creatorcontrib><description>[Problem] To provide a compound which may be used in treating diseases in which a calcium sensing receptor (CaSR) is concerned, particularly hyperparathyroidism. [Means for Resolution] It was found that novel pyrrolidine derivatives which are characterized by the possession of aminomethyl group substituted with arylalkyl group or the like, or salts thereof, have excellent CaSR agonistic regulatory activity and also have excellent selectivity with CYP2D6 inhibitory activity having a possibility of causing drug interaction. Based on the above, these novel pyrrolidine derivatives are useful as therapeutic agents for treating diseases in which CaSR is concerned (hyperparathyroidism, renal osteodystrophy, hypercalcemia and the like).</description><language>eng ; fre</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20061123&amp;DB=EPODOC&amp;CC=CA&amp;NR=2608957A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20061123&amp;DB=EPODOC&amp;CC=CA&amp;NR=2608957A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TERADA, YOH</creatorcontrib><creatorcontrib>KAMIKUBO, TAKASHI</creatorcontrib><creatorcontrib>SANAGI, MASANAO</creatorcontrib><creatorcontrib>TAKAHASHI, TAISUKE</creatorcontrib><creatorcontrib>HACHIYA, SHUNICHIRO</creatorcontrib><creatorcontrib>SEO, RYUSHI</creatorcontrib><creatorcontrib>MUKAI, HANA</creatorcontrib><creatorcontrib>MATSUURA, KEISUKE</creatorcontrib><creatorcontrib>YOSHIHARA, KOUSEI</creatorcontrib><creatorcontrib>OKU, MAKOTO</creatorcontrib><creatorcontrib>SHIN, TAKASHI</creatorcontrib><title>PYRROLIDINE DERIVATIVE OR SALT THEREOF</title><description>[Problem] To provide a compound which may be used in treating diseases in which a calcium sensing receptor (CaSR) is concerned, particularly hyperparathyroidism. [Means for Resolution] It was found that novel pyrrolidine derivatives which are characterized by the possession of aminomethyl group substituted with arylalkyl group or the like, or salts thereof, have excellent CaSR agonistic regulatory activity and also have excellent selectivity with CYP2D6 inhibitory activity having a possibility of causing drug interaction. Based on the above, these novel pyrrolidine derivatives are useful as therapeutic agents for treating diseases in which CaSR is concerned (hyperparathyroidism, renal osteodystrophy, hypercalcemia and the like).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFALiAwK8vfxdPH0c1VwcQ3yDHMM8QxzVfAPUgh29AlRCPFwDXL1d-NhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfHOjkZmBhaWpuaOhsZEKAEAkkAjQw</recordid><startdate>20061123</startdate><enddate>20061123</enddate><creator>TERADA, YOH</creator><creator>KAMIKUBO, TAKASHI</creator><creator>SANAGI, MASANAO</creator><creator>TAKAHASHI, TAISUKE</creator><creator>HACHIYA, SHUNICHIRO</creator><creator>SEO, RYUSHI</creator><creator>MUKAI, HANA</creator><creator>MATSUURA, KEISUKE</creator><creator>YOSHIHARA, KOUSEI</creator><creator>OKU, MAKOTO</creator><creator>SHIN, TAKASHI</creator><scope>EVB</scope></search><sort><creationdate>20061123</creationdate><title>PYRROLIDINE DERIVATIVE OR SALT THEREOF</title><author>TERADA, YOH ; KAMIKUBO, TAKASHI ; SANAGI, MASANAO ; TAKAHASHI, TAISUKE ; HACHIYA, SHUNICHIRO ; SEO, RYUSHI ; MUKAI, HANA ; MATSUURA, KEISUKE ; YOSHIHARA, KOUSEI ; OKU, MAKOTO ; SHIN, TAKASHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CA2608957A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2006</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TERADA, YOH</creatorcontrib><creatorcontrib>KAMIKUBO, TAKASHI</creatorcontrib><creatorcontrib>SANAGI, MASANAO</creatorcontrib><creatorcontrib>TAKAHASHI, TAISUKE</creatorcontrib><creatorcontrib>HACHIYA, SHUNICHIRO</creatorcontrib><creatorcontrib>SEO, RYUSHI</creatorcontrib><creatorcontrib>MUKAI, HANA</creatorcontrib><creatorcontrib>MATSUURA, KEISUKE</creatorcontrib><creatorcontrib>YOSHIHARA, KOUSEI</creatorcontrib><creatorcontrib>OKU, MAKOTO</creatorcontrib><creatorcontrib>SHIN, TAKASHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TERADA, YOH</au><au>KAMIKUBO, TAKASHI</au><au>SANAGI, MASANAO</au><au>TAKAHASHI, TAISUKE</au><au>HACHIYA, SHUNICHIRO</au><au>SEO, RYUSHI</au><au>MUKAI, HANA</au><au>MATSUURA, KEISUKE</au><au>YOSHIHARA, KOUSEI</au><au>OKU, MAKOTO</au><au>SHIN, TAKASHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRROLIDINE DERIVATIVE OR SALT THEREOF</title><date>2006-11-23</date><risdate>2006</risdate><abstract>[Problem] To provide a compound which may be used in treating diseases in which a calcium sensing receptor (CaSR) is concerned, particularly hyperparathyroidism. [Means for Resolution] It was found that novel pyrrolidine derivatives which are characterized by the possession of aminomethyl group substituted with arylalkyl group or the like, or salts thereof, have excellent CaSR agonistic regulatory activity and also have excellent selectivity with CYP2D6 inhibitory activity having a possibility of causing drug interaction. Based on the above, these novel pyrrolidine derivatives are useful as therapeutic agents for treating diseases in which CaSR is concerned (hyperparathyroidism, renal osteodystrophy, hypercalcemia and the like).</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre
recordid cdi_epo_espacenet_CA2608957A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PYRROLIDINE DERIVATIVE OR SALT THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T13%3A40%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TERADA,%20YOH&rft.date=2006-11-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECA2608957A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true